---

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

---

 

FORM 8-K

 

---

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): April 27, 2004

 

---

 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 

---

 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

0-24260		11-3131700
(Commission File Number)		(I.R.S. Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 

---

---

ITEM 5. OTHER EVENTS

 

On April 27, 2004 Amedisys, Inc., “the Company”, issued a press release attached hereto as Exhibit 99.1 to announce that a new director has been appointed to its Board of Directors.

 

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

 

(a)		Financial Statements of Business Acquired.
		Not applicable.
(b)		Pro Forma Financial Information.
		Not applicable.
(c)		Exhibit     No.
		99.1 (i)		Press release dated April 27, 2004 to announce the appointment of Donald A. Washburn to Amedisys’ Board of Directors

---

(i)	Filed herewith.

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.
By:		/s/ Gregory H. Browne
		Gregory H. Browne
		Chief Financial Officer
DATE: April 27, 2004